comparemela.com

Latest Breaking News On - ஜியோவானி திரவேற்சொ - Page 3 : comparemela.com

Stents inspired by kirigami could deliver drugs to tubular organs

Stents inspired by kirigami could deliver drugs to tubular organs
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

| Science Codex

| Science Codex
sciencecodex.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencecodex.com Daily Mail and Mail on Sunday newspapers.

Kirigami-inspired stent offers new drug delivery method for tubular organs

Kirigami-inspired stent offers new drug delivery method for tubular organs
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Research on therapies for herpes and diabetes win STAT Madness

Martine Aubert, left, and Keith Jerome of the Fred Hutchinson Cancer Research Center led one of the teams that won STAT Madness. Fred Hutchinson Cancer Research Center From curing herpes to treating diabetes in a new way, their innovations might one day treat some of the world’s most prevalent health problems. This year’s two finalists in STAT Madness, a bracket-style competition that showcases cutting-edge research across the biomedical sciences, harnessed new approaches to devise possible therapies that could help millions of people with all-too-common maladies. One team, from the Fred Hutchinson Cancer Research Center, developed a gene-editing technique with the potential to effectively treat and even cure herpes. The other finalist, a group from the Massachusetts Institute of Technology and Brigham and Women’s Hospital, devised a liquid solution that coats the small intestine with a temporary adhesive, a noninvasive technique with wide applications from

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.